OMAHA, Neb. (August  10, 2016) Transgenomic, Inc. (NASDAQ: TBIO), today announced that the company will hold its Second Quarter 2016 Financial Results and Business Update Conference Call on August 12, 2016 at 5:00 PM EDT. The company will present an overview of financial results for the second quarter in a press release issued at 4:00 PM EDT that day.

To participate in the call, dial 877-876-9177 from the U.S. and Canada, or 785-424-1666 from international locations, and enter conference ID: TRANS. The call will be webcast live and can be accessed at https://www.webcaster4.com/Webcast/Page/1139/16704, which is also available at the Investor page of Transgenomic’s website.

A replay will be available for two weeks beginning approximately two hours after the call’s conclusion, until 11:59 PM EDT August 26, 2016. To access the replay, dial 800-839-3742 (domestic) or 402-220-2979 (international). The conference call will also be archived at the Investor page of the company’s website.

About Transgenomic, Inc.

Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD-PCR. Transgenomic also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies. Transgenomic’s diagnostic technologies are designed to improve medical diagnoses and patient outcomes.

Contacts:

Media:                                                                                    

BLL Partners LLC

Barbara Lindheim

212-584-2276                                                               

blindheim@bllbiopartners.com

Investors:

Transgenomic Investor Relations

investor.relations@transgenomic.com